Genes,DisGeNET_Term,DisGeNET_Pvalue_Adjusted,GeDiPNet_Term,GeDiPNet_Pvalue_Adjusted,Orphanet_Term,Orphanet_Pvalue_Adjusted,Virus_Host_Term,Virus_Host_Pvalue_Adjusted,Host organism(s)_Intact,Confidence value(s)_Intact,Taxid interactor A_Intact,Taxid interactor B_Intact
CXCL8,Epstein-Barr Virus Infections; Kaposi Sarcoma; Renal interstitial fibrosis; Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome; Vascular Diseases,0.0050717829061455; 0.0050717829061455; 0.0050717829061455; 0.0052866579818966; 0.0057123722665394,,,Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951,0.0029348234721257; 0.0029348234721257,,,Homo sapiens HLMVEC lung microvascular endothelial cell;Homo sapiens diploid fibroblast;In vitro,0.61,Homo sapiens;chemical synthesis,Homo sapiens;chemical synthesis
EGR1,Epstein-Barr Virus Infections; Kaposi Sarcoma; Renal interstitial fibrosis; Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome; Vascular Diseases,0.0050717829061455; 0.0050717829061455; 0.0050717829061455; 0.0052866579818966; 0.0057123722665394,,,Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951,0.0029348234721257; 0.0029348234721257,,,yeasx,0.37,Homo sapiens,Bacillus anthracis;Homo sapiens
SLC12A3,Epstein-Barr Virus Infections; Kaposi Sarcoma; Vascular Diseases,0.0050717829061455; 0.0050717829061455; 0.0057123722665394,,,,,,,In vitro,0.35,chemical synthesis,Homo sapiens
